MURA Mural Oncology plc

Nasdaq


$ 2.09 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 15:59:59 EDT
QQQ $ 611.41 $ 0.00 (0 %)
DIA $ 466.73 $ 1.78 (0.38 %)
SPY $ 671.87 $ 3.53 (0.53 %)
TLT $ 91.46 $ 0.00 (0 %)
GLD $ 378.30 $ -2.69 (-0.71 %)
$ 2.1
$ 2.09
$ 2.08 x 7,900
$ 2.12 x 100
$ 2.08 - $ 2.09
$ 0.95 - $ 4.74
228,261
na
36.38M
$ -0.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-26-2024 12-31-2023 10-K
8 12-14-2023 09-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Mural Oncology (NASDAQ:MURA) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1....

 mural-oncology-shares-surge-as-company-explores-strategic-alternatives-whats-going-on

Shares of Mural Oncology plc (NASDAQ: MURA) are soaring Monday following the company's announcement that it will discontinu...

Core News & Articles

HC Wainwright & Co. analyst Andres Maldonado maintains Mural Oncology (NASDAQ:MURA) with a Buy and lowers the price targ...

 mural-oncologys-ovarian-cancer-combo-drug-trial-disappoints-stock-plunges

Mural Oncology ends nemvaleukin development for ovarian cancer after ARTISTRY-7 trial misses survival goals. Phase 2 trials for...

Core News & Articles

Jones Trading analyst Soumit Roy downgrades Mural Oncology (NASDAQ:MURA) from Buy to Hold.

Core News & Articles

In the pre-specified interim analysis conducted by the independent data monitoring committee, nemvaleukin in combination with p...

Core News & Articles

HC Wainwright & Co. analyst Andres Maldonado reiterates Mural Oncology (NASDAQ:MURA) with a Buy and maintains $18 price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION